{"id":912049,"date":"2025-11-20T08:03:09","date_gmt":"2025-11-20T13:03:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/"},"modified":"2025-11-20T08:03:09","modified_gmt":"2025-11-20T13:03:09","slug":"quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/","title":{"rendered":"Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Quantum-Si Highlights Significant Development Advancements for Proteus<\/b><b>\u2122<\/b><b> and Industry Leading Technology Pipeline at Investor &amp; Analyst Day<\/b><\/p>\n<p class=\"bwalignc\"><i>Expect Proteus launch by end of 2026<\/i><\/p>\n<p class=\"bwalignc\"><i>Demonstration of the detection of all 20 amino acids by end of 2026<\/i><\/p>\n<p class=\"bwalignc\"><i>New controlled cleavage chemistry unlocks path to billions of sequencing reads<\/i><\/p>\n<p>BRANFORD, Conn.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.quantum-si.com%2F&amp;esheet=54359376&amp;newsitemid=20251120536284&amp;lan=en-US&amp;anchor=Quantum-Si+Incorporated&amp;index=1&amp;md5=fa45e2ed031f0330bdf227f74d938e63\">Quantum-Si Incorporated<\/a> (Nasdaq: QSI) (\u201cQuantum-Si,\u201d \u201cQSI\u201d or the \u201cCompany\u201d), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the highlights of its Investor &amp; Analyst Day that was hosted in New York City on November 19, 2025.<\/p>\n<p><b>Key Highlights:<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nProteus\u2122 platform on track for end of 2026 launch<\/p>\n<\/li>\n<li>\nEarly Access Program expected to start in the summer of 2026<\/p>\n<\/li>\n<li>\nExpect Proteus to have coverage of 18 amino acids at launch and overall sequencing performance is expected to far exceed Platinum<sup>\u00ae<\/sup> Pro<\/p>\n<\/li>\n<li>\nAccelerated amino acid recognizer program expected to demonstrate detection of all 20 amino acids in 2026 and deliver the capability to market on Proteus in 2027<\/p>\n<\/li>\n<li>\nUnveiled new controlled cleavage sequencing chemistry that when combined with the Proteus architecture will be able to deliver billions of sequencing reads<\/p>\n<\/li>\n<li>\nA suite of post-translational modification (PTM) methods will be utilized to deliver broad PTM analysis capabilities on the Proteus platform<\/p>\n<\/li>\n<li>\nKey dates were announced for product pricing (Q2 2026); product launch capabilities (Q3 2026); and a Platinum Pro upgrade program (Q3 2026)<\/p>\n<\/li>\n<\/ul>\n<p>\n\u201cWe were pleased to present the significant progress we have made with our Proteus development program and provide the data behind why we believe this will be a market changing product in the field of proteomics\u201d said Jeff Hawkins, President and Chief Executive Officer of Quantum-Si. \u201cNot only does Proteus remain on track for launch at the end of 2026, but our targeted investments in new technology development have also yielded yet another leap forward in capabilities by demonstrating the feasibility of a controlled cleavage sequencing chemistry.\u201d<\/p>\n<p>\nHawkins continued, \u201cWhen you combine the Proteus architecture with coverage of all 20 amino acids and our new controlled cleavage chemistry, we will have the full suite of technologies in hand to scale to a level of sequencing performance, output and costs that was never possible with our current architecture and will represent a daunting challenge for anyone to match. The culmination of the launch of Proteus and our continued execution on our long-term technology roadmap is expected to unlock significant value for our shareholders.\u201d<\/p>\n<p><b>Webcast Replay<\/b><\/p>\n<p>\nA replay of the Investor &amp; Analyst Day event is available through the Investor Relations section of Quantum-Si\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.quantum-si.com%2F&amp;esheet=54359376&amp;newsitemid=20251120536284&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.quantum-si.com%2F&amp;index=2&amp;md5=76216282b6d841e7e7f45363a7ded926\">https:\/\/ir.quantum-si.com\/<\/a>. The archived webcast will be available for at least 90 days.<\/p>\n<p><b>About Quantum-Si Incorporated<\/b><\/p>\n<p>\nQuantum-Si is transforming proteomics with a benchtop platform that brings single-molecule protein analysis to every lab, everywhere. The Company\u2019s platform enables real-time kinetic-based detection and allows researchers to move beyond traditional, multistep workflows and directly access dynamic, functional protein insights with unparalleled resolution. By making protein analysis simpler, faster, and more informative, Quantum-Si is accelerating proteomic discoveries to improve the way we live. Learn more at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.quantum-si.com&amp;esheet=54359376&amp;newsitemid=20251120536284&amp;lan=en-US&amp;anchor=quantum-si.com&amp;index=3&amp;md5=fb3b7e74f099d319e934b84264098b47\">quantum-si.com<\/a> or follow us on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fquantum-si&amp;esheet=54359376&amp;newsitemid=20251120536284&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=4&amp;md5=78d6f18f2781d4e5926a0c5e4ae4cab7\">LinkedIn<\/a> or <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fquantum_si&amp;esheet=54359376&amp;newsitemid=20251120536284&amp;lan=en-US&amp;anchor=X&amp;index=5&amp;md5=54263f71407e2dd21fe6e73310c093b6\">X<\/a>.<\/p>\n<p><b>Forward Looking Statements<\/b><\/p>\n<p>\nThis press release includes \u201cforward-looking statements\u201d within the meaning of the \u201csafe harbor\u201d provisions of the United States Private Securities Litigation Reform Act of 1995. The actual results of the Company may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as \u201cexpect,\u201d \u201cestimate,\u201d \u201cproject,\u201d \u201cbudget,\u201d \u201cforecast,\u201d \u201canticipate,\u201d \u201cintend,\u201d \u201cplan,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201ccould,\u201d \u201cshould,\u201d \u201cbelieves,\u201d \u201cpredicts,\u201d \u201cpotential,\u201d \u201ccontinue,\u201d and similar expressions (or the negative versions of such words or expressions) are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company\u2019s expectations with respect to future performance and development and commercialization of products and services, its anticipated cash runway, anticipated data and product launches (including Proteus), investor confidence in Quantum-Si and our strategic roadmap, and any financial guidance. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from those discussed in the forward-looking statements. Most of these factors are outside the Company\u2019s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the inability to maintain the listing of the Company\u2019s Class A common stock on The Nasdaq Stock Market; the ability of the Company to grow and manage growth and retain its key employees; the Company\u2019s ongoing leadership transitions and succession planning; changes in applicable laws or regulations; the ability of the Company to raise financing in the future; the success, cost and timing of the Company\u2019s product development and commercialization activities, including the use and benefit of artificial intelligence in these and other activities; the commercialization and adoption of the Company\u2019s existing products and the success of any product the Company may offer in the future; the potential attributes and benefits of the Company\u2019s commercialized Platinum protein sequencing instruments and kits and the Company\u2019s other products (including Proteus) once commercialized; the Company\u2019s ability to obtain and maintain regulatory approval for its products, and any related restrictions and limitations of any approved product; the Company\u2019s ability to identify, in-license or acquire additional technology; the Company\u2019s ability to maintain its existing lease, license, manufacture and supply agreements; the Company\u2019s ability to compete with other companies currently marketing or engaged in the development or commercialization of products and services that serve customers engaged in proteomic analysis, many of which have greater financial and marketing resources than the Company; the size and growth potential of the markets for the Company\u2019s products and services, and its ability to serve those markets once commercialized, either alone or in partnership with others; the Company\u2019s estimates regarding future expenses, future revenue, capital requirements and needs for additional financing; the Company\u2019s financial performance; the Company&#8217;s defense and initiation of litigation matters; and other risks and uncertainties described under \u201cRisk Factors\u201d in the Company\u2019s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q and in the Company\u2019s other filings with the SEC. The Company cautions that the foregoing list of factors is not exclusive. The Company cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251120536284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20251120536284\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20251120536284\/en\/<\/a><\/span><\/p>\n<p><b>Investor and Media<br \/>\n<\/b><br \/>Jeff Keyes<br \/>\n<br \/>Chief Financial Officer<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:ir@quantum-si.com\">ir@quantum-si.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> Connecticut United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Hardware Other Professional Services Other Health Technology Pharmaceutical Oncology Professional Services Biometrics General Health Other Technology Science Biotechnology Other Science Health Research<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251120536284\/en\/2019726\/3\/QSI_LOGO_WORDMARK_BLUE.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day Expect Proteus launch by end of 2026 Demonstration of the detection of all 20 amino acids by end of 2026 New controlled cleavage chemistry unlocks path to billions of sequencing reads BRANFORD, Conn.&#8211;(BUSINESS WIRE)&#8211;Quantum-Si Incorporated (Nasdaq: QSI) (\u201cQuantum-Si,\u201d \u201cQSI\u201d or the \u201cCompany\u201d), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the highlights of its Investor &amp; Analyst Day that was hosted in New York City on November 19, 2025. Key Highlights: Proteus\u2122 platform on track for end of 2026 launch Early Access Program expected to start in the summer of 2026 Expect Proteus to have coverage of 18 amino &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-912049","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day Expect Proteus launch by end of 2026 Demonstration of the detection of all 20 amino acids by end of 2026 New controlled cleavage chemistry unlocks path to billions of sequencing reads BRANFORD, Conn.&#8211;(BUSINESS WIRE)&#8211;Quantum-Si Incorporated (Nasdaq: QSI) (\u201cQuantum-Si,\u201d \u201cQSI\u201d or the \u201cCompany\u201d), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the highlights of its Investor &amp; Analyst Day that was hosted in New York City on November 19, 2025. Key Highlights: Proteus\u2122 platform on track for end of 2026 launch Early Access Program expected to start in the summer of 2026 Expect Proteus to have coverage of 18 amino &hellip; Continue reading &quot;Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-20T13:03:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251120536284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day\",\"datePublished\":\"2025-11-20T13:03:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\\\/\"},\"wordCount\":1161,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251120536284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\\\/\",\"name\":\"Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251120536284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2025-11-20T13:03:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251120536284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20251120536284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/","og_locale":"en_US","og_type":"article","og_title":"Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day - Market Newsdesk","og_description":"Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day Expect Proteus launch by end of 2026 Demonstration of the detection of all 20 amino acids by end of 2026 New controlled cleavage chemistry unlocks path to billions of sequencing reads BRANFORD, Conn.&#8211;(BUSINESS WIRE)&#8211;Quantum-Si Incorporated (Nasdaq: QSI) (\u201cQuantum-Si,\u201d \u201cQSI\u201d or the \u201cCompany\u201d), a proteomics technology company redefining protein analysis through single-molecule detection, today announced the highlights of its Investor &amp; Analyst Day that was hosted in New York City on November 19, 2025. Key Highlights: Proteus\u2122 platform on track for end of 2026 launch Early Access Program expected to start in the summer of 2026 Expect Proteus to have coverage of 18 amino &hellip; Continue reading \"Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-20T13:03:09+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251120536284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day","datePublished":"2025-11-20T13:03:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/"},"wordCount":1161,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251120536284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/","name":"Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251120536284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2025-11-20T13:03:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251120536284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20251120536284r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-si-highlights-significant-development-advancements-for-proteus-and-industry-leading-technology-pipeline-at-investor-analyst-day\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Quantum-Si Highlights Significant Development Advancements for Proteus\u2122 and Industry Leading Technology Pipeline at Investor &amp; Analyst Day"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/912049","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=912049"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/912049\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=912049"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=912049"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=912049"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}